{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T17:25:54Z","timestamp":1789838754277,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"RIKEN TRIP initiative","award":["AGIS"],"award-info":[{"award-number":["AGIS"]}]},{"DOI":"10.13039\/501100020963","name":"Moonshot Research and Development Program","doi-asserted-by":"publisher","award":["JPMJMS2022-9"],"award-info":[{"award-number":["JPMJMS2022-9"]}],"id":[{"id":"10.13039\/501100020963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"japan society for the promotion of science KAKENHI","doi-asserted-by":"crossref","award":["24K10131"],"award-info":[{"award-number":["24K10131"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science KAKENHI","doi-asserted-by":"crossref","award":["21K06933"],"award-info":[{"award-number":["21K06933"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"DOI":"10.1007\/s00428-026-04680-2","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:58:51Z","timestamp":1787878731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Deep learning augmented pathological grading and intraductal carcinoma of the prostate signatures improve recurrence prediction after intensity-modulated radiation therapy"],"prefix":"10.1007","author":[{"given":"Mami","family":"Takadate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rihito","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Marugame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyunya","family":"Iwazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Tsutsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Akatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Go","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Haga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mizowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4855-4366","authenticated-orcid":false,"given":"Toyonori","family":"Tsuzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"4680_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4680_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10:63\u201389. https:\/\/doi.org\/10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"4680_CR3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eururo.2019.08.005","volume":"77","author":"MB Culp","year":"2020","unstructured":"Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A (2020) Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol 77:38\u201352. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.005","journal-title":"Eur Urol"},{"key":"4680_CR4","volume-title":"NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 1.2025","author":"National Comprehensive Cancer Network","year":"2025","unstructured":"National Comprehensive Cancer Network (2025) NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 1.2025. NCCN, Plymouth Meeting"},{"key":"4680_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","volume":"11","author":"AJ Chang","year":"2014","unstructured":"Chang AJ, Autio KA, Roach M 3rd, Scher HI (2014) High-risk prostate cancer: classification and therapy. Nat Rev Clin Oncol 11:308\u2013323. https:\/\/doi.org\/10.1038\/nrclinonc.2014.68","journal-title":"Nat Rev Clin Oncol"},{"key":"4680_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969\u2013974. https:\/\/doi.org\/10.1001\/jama.280.11.969","journal-title":"JAMA"},{"key":"4680_CR7","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1002\/cncr.26169","volume":"117","author":"MR Cooperberg","year":"2011","unstructured":"Cooperberg MR, Hilton JF, Carroll PR (2011) The CAPRA-S score: a straightforward tool for improved prediction of outcomes after radical prostatectomy. Cancer 117:5039\u20135046. https:\/\/doi.org\/10.1002\/cncr.26169","journal-title":"Cancer"},{"key":"4680_CR8","doi-asserted-by":"publisher","unstructured":"Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40:244\u2013252. https:\/\/doi.org\/10.1097\/PAS.0000000000000530","DOI":"10.1097\/PAS.0000000000000530"},{"key":"4680_CR9","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/iju.12657","volume":"22","author":"T Tsuzuki","year":"2015","unstructured":"Tsuzuki T (2015) Intraductal carcinoma of the prostate: a comprehensive and updated review. Int J Urol 22:140\u2013145. https:\/\/doi.org\/10.1111\/iju.12657","journal-title":"Int J Urol"},{"key":"4680_CR10","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.eururo.2017.03.013","volume":"72","author":"LH Porter","year":"2017","unstructured":"Porter LH, Lawrence MG, Ilic D et al (2017) Systematic review links the prevalence of intraductal carcinoma of the prostate to prostate cancer risk categories. Eur Urol 72:492\u2013495. https:\/\/doi.org\/10.1016\/j.eururo.2017.03.013","journal-title":"Eur Urol"},{"key":"4680_CR11","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1097\/JU.0000000000001290","volume":"204","author":"N Miura","year":"2020","unstructured":"Miura N, Mori K, Mostafaei H et al (2020) The prognostic impact of intraductal carcinoma of the prostate: a systematic review and meta-analysis. J Urol 204:909\u2013917. https:\/\/doi.org\/10.1097\/JU.0000000000001290","journal-title":"J Urol"},{"key":"4680_CR12","unstructured":"European Association of Urology (2020) EAU Guidelines on Prostate Cancer: Classification and staging systems. https:\/\/uroweb.org\/guidelines\/prostate-cancer\/chapter\/classification-and-staging-systems. Accessed 9 June 2025"},{"key":"4680_CR13","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/s41379-022-01111-w","volume":"35","author":"Y Yu","year":"2022","unstructured":"Yu Y, Lajkosz K, Finelli A et al (2022) Impact of cribriform pattern 4 and intraductal prostatic carcinoma on National Comprehensive Cancer Network (NCCN) and Cancer of Prostate Risk Assessment (CAPRA) patient stratification. Mod Pathol 35:1695\u20131701. https:\/\/doi.org\/10.1038\/s41379-022-01111-w","journal-title":"Mod Pathol"},{"key":"4680_CR14","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1016\/j.clgc.2022.01.003","volume":"20","author":"R Jeyapala","year":"2022","unstructured":"Jeyapala R, Kamdar S, Olkhov-Mitsel E et al (2022) Combining CAPRA-S with tumor IDC\/C features improves the prognostication of biochemical recurrence in prostate cancer patients. Clin Genitourin Cancer 20:e217\u2013e226. https:\/\/doi.org\/10.1016\/j.clgc.2022.01.003","journal-title":"Clin Genitourin Cancer"},{"key":"4680_CR15","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/jcp-2023-209222","volume":"78","author":"NJ Nguyen","year":"2025","unstructured":"Nguyen NJ, Liu K, Lajkosz K et al (2025) Addition of cribriform pattern 4 and intraductal prostatic carcinoma into the CAPRA-S tool improves post-radical prostatectomy patient stratification in a multi-institutional cohort. J Clin Pathol 78:805\u2013813. https:\/\/doi.org\/10.1136\/jcp-2023-209222","journal-title":"J Clin Pathol"},{"key":"4680_CR16","doi-asserted-by":"publisher","first-page":"100852","DOI":"10.1016\/j.modpat.2025.100852","volume":"38","author":"NJ Nguyen","year":"2025","unstructured":"Nguyen NJ, Liu K, Lajkosz K et al (2025) Magnetic resonance imaging (MRI)-adapted prostate cancer risk tool incorporating cribriform and intraductal carcinoma. Mod Pathol 38:100852. https:\/\/doi.org\/10.1016\/j.modpat.2025.100852","journal-title":"Mod Pathol"},{"key":"4680_CR17","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1111\/cas.15392","volume":"113","author":"R Aizawa","year":"2022","unstructured":"Aizawa R, Tsuzuki T, Haga H et al (2022) Clinical significance of intraductal carcinoma of the prostate as a predictive factor after intensity-modulated radiation therapy. Cancer Sci 113:2425\u20132433. https:\/\/doi.org\/10.1111\/cas.15392","journal-title":"Cancer Sci"},{"key":"4680_CR18","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","volume":"25","author":"G Campanella","year":"2019","unstructured":"Campanella G, Hanna MG, Geneslaw L et al (2019) Clinical-grade computational pathology using weakly supervised deep learning on whole-slide images. Nat Med 25:1301\u20131309. https:\/\/doi.org\/10.1038\/s41591-019-0508-1","journal-title":"Nat Med"},{"key":"4680_CR19","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41591-021-01620-2","volume":"28","author":"W Bulten","year":"2022","unstructured":"Bulten W, Kartasalo K, Chen PC et al (2022) Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge. Nat Med 28:154\u2013163. https:\/\/doi.org\/10.1038\/s41591-021-01620-2","journal-title":"Nat Med"},{"key":"4680_CR20","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1038\/s41467-019-13647-8","volume":"10","author":"Y Yamamoto","year":"2019","unstructured":"Yamamoto Y, Tsuzuki T, Akatsuka J et al (2019) Automated acquisition of explainable knowledge from unannotated histopathology images. Nat Commun 10:5642. https:\/\/doi.org\/10.1038\/s41467-019-13647-8","journal-title":"Nat Commun"},{"key":"4680_CR21","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s10147-019-01478-y","volume":"24","author":"R Aizawa","year":"2019","unstructured":"Aizawa R, Takayama K, Nakamura K et al (2019) Ten-year outcomes of high-dose intensity-modulated radiation therapy for nonmetastatic prostate cancer with unfavorable risk: early initiation of salvage therapy may replace long-term adjuvant androgen deprivation. Int J Clin Oncol 24:1247\u20131255. https:\/\/doi.org\/10.1007\/s10147-019-01478-y","journal-title":"Int J Clin Oncol"},{"key":"4680_CR22","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1007\/s10147-021-02002-x","volume":"26","author":"R Aizawa","year":"2021","unstructured":"Aizawa R, Nakamura K, Norihisa Y et al (2021) Long-term safety of high-dose whole pelvic intensity-modulated radiation therapy for high-risk localized prostate cancer through 10-year follow-up. Int J Clin Oncol 26:2113\u20132122. https:\/\/doi.org\/10.1007\/s10147-021-02002-x","journal-title":"Int J Clin Oncol"},{"key":"4680_CR23","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","volume":"20","author":"JE McNeal","year":"1996","unstructured":"McNeal JE, Yemoto CE (1996) Spread of adenocarcinoma within prostatic ducts and acini: morphologic and clinical correlations. Am J Surg Pathol 20:802\u2013814. https:\/\/doi.org\/10.1097\/00000478-199607000-00003","journal-title":"Am J Surg Pathol"},{"key":"4680_CR24","doi-asserted-by":"publisher","unstructured":"Dosovitskiy A, Beyer L, Kolesnikov A et al (2020) An image is worth 16\u00d716 words: transformers for image recognition at scale. https:\/\/doi.org\/10.48550\/arXiv.2010.11929. arXiv:2010.11929","DOI":"10.48550\/arXiv.2010.11929"},{"key":"4680_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41746-025-02193-x","volume":"9","author":"J Akatsuka","year":"2026","unstructured":"Akatsuka J, Tsutsumi K, Takadate M et al (2026) Clinically informed intermediate reasoning enables generalizable prostate cancer prognostication through machine learning in limited settings. npj Digit Med 9:19. https:\/\/doi.org\/10.1038\/s41746-025-02193-x","journal-title":"npj Digit Med"},{"key":"4680_CR26","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/pros.22786","volume":"74","author":"K Kimura","year":"2014","unstructured":"Kimura K, Tsuzuki T, Kato M et al (2014) Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens. Prostate 74:680\u2013687. https:\/\/doi.org\/10.1002\/pros.22786","journal-title":"Prostate"},{"key":"4680_CR27","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.ejca.2014.03.009","volume":"50","author":"D Trudel","year":"2014","unstructured":"Trudel D, Downes MR, Sykes J, Kron KJ, Trachtenberg J, van der Kwast TH (2014) Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort. Eur J Cancer 50:1610\u20131616. https:\/\/doi.org\/10.1016\/j.ejca.2014.03.009","journal-title":"Eur J Cancer"},{"key":"4680_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.clgc.2023.10.005","volume":"22","author":"K Miyajima","year":"2024","unstructured":"Miyajima K, Sato S, Uchida N et al (2024) Clinical significance of intraductal carcinoma of the prostate after high-dose brachytherapy with external beam radiation therapy: a single-institution series and an updated meta-analysis. Clin Genitourin Cancer 22:149\u2013156e1. https:\/\/doi.org\/10.1016\/j.clgc.2023.10.005","journal-title":"Clin Genitourin Cancer"},{"key":"4680_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/pros.23438","volume":"78","author":"M Kato","year":"2018","unstructured":"Kato M, Kimura K, Hirakawa A et al (2018) Prognostic parameter for high-risk prostate cancer patients at initial presentation. Prostate 78:11\u201316. https:\/\/doi.org\/10.1002\/pros.23438","journal-title":"Prostate"},{"key":"4680_CR30","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/modpathol.2015.146","volume":"29","author":"M Kato","year":"2016","unstructured":"Kato M, Tsuzuki T, Kimura K et al (2016) The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation. Mod Pathol 29:166\u2013173. https:\/\/doi.org\/10.1038\/modpathol.2015.146","journal-title":"Mod Pathol"},{"key":"4680_CR31","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1007\/s10147-020-01756-0","volume":"25","author":"M Kato","year":"2020","unstructured":"Kato M, Hirakawa A, Kobayashi Y et al (2020) Effect of core needle biopsy number on intraductal carcinoma of the prostate diagnosis in patients with metastatic hormone-sensitive prostate cancer. Int J Clin Oncol 25:2130\u20132137. https:\/\/doi.org\/10.1007\/s10147-020-01756-0","journal-title":"Int J Clin Oncol"},{"issue":"20000401","key":"4680_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/(SICI)1097-0045","volume":"43","author":"RJ Cohen","year":"2000","unstructured":"Cohen RJ, McNeal JE, Baillie T (2000) Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression. Prostate 43(20000401):11\u201319. https:\/\/doi.org\/10.1002\/(SICI)1097-0045. ::AID-PROS3>3.0.CO;2-B","journal-title":"Prostate"},{"key":"4680_CR33","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1470-2045(19)30739-9","volume":"21","author":"W Bulten","year":"2020","unstructured":"Bulten W, Pinckaers H, van Boven H et al (2020) Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol 21:233\u2013241. https:\/\/doi.org\/10.1016\/S1470-2045(19)30739-9","journal-title":"Lancet Oncol"},{"key":"4680_CR34","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41586-024-07894-z","volume":"634","author":"X Wang","year":"2024","unstructured":"Wang X, Zhao J, Marostica E et al (2024) A pathology foundation model for cancer diagnosis and prognosis prediction. Nature 634:970\u2013978. https:\/\/doi.org\/10.1038\/s41586-024-07894-z","journal-title":"Nature"},{"key":"4680_CR35","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41591-024-03141-0","volume":"30","author":"E Vorontsov","year":"2024","unstructured":"Vorontsov E, Bozkurt A, Casson A et al (2024) A foundation model for clinical-grade computational pathology and rare cancers detection. Nat Med 30:2924\u20132935. https:\/\/doi.org\/10.1038\/s41591-024-03141-0","journal-title":"Nat Med"},{"key":"4680_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11604-024-01646-9","volume":"43","author":"T Otani","year":"2025","unstructured":"Otani T, Nakamoto R, Umeoka S, Nakamoto Y (2025) PSMA PET\/CT imaging and its application to prostate cancer treatment. Jpn J Radiol 43:1\u201312. https:\/\/doi.org\/10.1007\/s11604-024-01646-9","journal-title":"Jpn J Radiol"},{"key":"4680_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1007\/s12149-021-01704-6","volume":"36","author":"T Otani","year":"2022","unstructured":"Otani T, Saga T, Ishimori T et al (2022) Detection efficacy of PET\/CT with 18F-FSU-880 in patients with suspected recurrent prostate cancer: a prospective single-center study. Ann Nucl Med 36:302\u2013309. https:\/\/doi.org\/10.1007\/s12149-021-01704-6","journal-title":"Ann Nucl Med"},{"key":"4680_CR38","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/jjco\/hyac035","volume":"52","author":"N Terada","year":"2022","unstructured":"Terada N, Aizawa R, Nihei K et al (2022) Narrative review of local prostate and metastasis-directed radiotherapy in the treatment of metastatic prostate cancer. Jpn J Clin Oncol 52:633\u2013641. https:\/\/doi.org\/10.1093\/jjco\/hyac035","journal-title":"Jpn J Clin Oncol"},{"key":"4680_CR39","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.21873\/anticanres.17623","volume":"45","author":"R Aizawa","year":"2025","unstructured":"Aizawa R, Ogata T, Goto T et al (2025) Clinical outcomes of metastasis-directed therapy for oligo-metastatic prostate cancer diagnosed using PSMA-PET\/CT or whole-body MRI. Anticancer Res 45:2515\u20132525. https:\/\/doi.org\/10.21873\/anticanres.17623","journal-title":"Anticancer Res"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04680-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04680-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04680-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:58:53Z","timestamp":1787878733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-026-04680-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":39,"alternative-id":["4680"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04680-2","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]},"assertion":[{"value":"18 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study followed the tenets of the Declaration of Helsinki and was approved by the ethical review boards of Kyoto University Graduate School of Medicine (R2496-1), NMSH (28-11-663), and RIKEN (Wako 2022-07).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was not obtained due to the retrospective nature of the study. Instead, consent was obtained in the form of an opt-out on our website, and those who rejected were excluded.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}